Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 3, 2015, Pages 598-608

  Bochner, Bruce S ^a   Zimmermann, Nives ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Medical Center   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

dectin; glycan; glycan binding proteins; glycobiology; selectin; sialic acid; Siglec; treatment

Indexed keywords

GLYCAN BINDING PROTEIN; GLYCOPROTEIN; IMMUNOGLOBULIN G; SELECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; UNCLASSIFIED DRUG; POLYSACCHARIDE; PROTEIN BINDING; REACTIVE OXYGEN METABOLITE;

ALLERGIC DISEASE; AMINO ACID SEQUENCE; AUTOIMMUNITY; CANCER IMMUNOLOGY; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; NEOPLASM; PATHOLOGY; PNEUMOCOCCAL INFECTION; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INFLAMMATION; NEOPLASMS; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SCHISTOSOMIASIS; SELECTINS; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; SIGNAL TRANSDUCTION;

EID: 84924347336     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.11.031     Document Type: Review

References (114)

1. B. Lepenies, J. Lee, and S. Sonkaria Targeting C-type lectin receptors with multivalent carbohydrate ligands Adv Drug Deliv Rev 65 2013 1271 1281
2. A.S. Powlesland, A. Quintero-Martinez, P.G. Lim, Z. Pipirou, M.E. Taylor, and K. Drickamer Engineered carbohydrate-recognition domains for glycoproteomic analysis of cell surface glycosylation and ligands for glycan-binding receptors Methods Enzymol 480 2010 165 179
3. G.A. Rabinovich, Y. van Kooyk, and B.A. Cobb Glycobiology of immune responses Ann N Y Acad Sci 1253 2012 1 15
4. S.R. Stowell, C.M. Arthur, R. McBride, O. Berger, N. Razi, and J. Heimburg-Molinaro Microbial glycan microarrays define key features of host-microbial interactions Nat Chem Biol 10 2014 470 476
5. A. Varki, and P. Gagneux Multifarious roles of sialic acids in immunity Ann N Y Acad Sci 1253 2012 16 36
6. A. Varki Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins Nature 446 2007 1023 1029
7. A. Varki, and T. Angata Siglecs - the major sub-family of I-type lectins Glycobiology 16 2006 1R 27R
8. P.R. Crocker, J.C. Paulson, and A. Varki Siglecs and their roles in the immune system Nat Rev Immunol 7 2007 255 266
9. S. von Gunten, and B.S. Bochner Basic and clinical immunology of Siglecs Ann N Y Acad Sci 1143 2008 61 82
10. S. Pillai, I.A. Netravali, A. Cariappa, and H. Mattoo Siglecs and immune regulation Annu Rev Immunol 30 2012 357 392
11. J.C. Paulson, M.S. Macauley, and N. Kawasaki Siglecs as sensors of self in innate and adaptive immune responses Ann N Y Acad Sci 1253 2012 37 48
12. P.R. Crocker, S.J. McMillan, and H.E. Richards CD33-related siglecs as potential modulators of inflammatory responses Ann N Y Acad Sci 1253 2012 102 111
13. M.S. Macauley, P.R. Crocker, and J.C. Paulson Siglec-mediated regulation of immune cell function in disease Nat Rev Immunol 14 2014 653 666
14. R.L. Schnaar Glycans and glycan binding proteins in immune regulation: a concise introduction to glycobiology for the allergist J Allergy Clin Immunol 135 2015 609 615
15. B.S. Bochner, R.A. Alvarez, P. Mehta, N.V. Bovin, O. Blixt, and J.R. White Glycan array screening reveals a candidate ligand for Siglec-8 J Biol Chem 280 2005 4307 4312
16. T. Kiwamoto, M.E. Brummet, F. Wu, M.G. Motari, D.F. Smith, and R.L. Schnaar Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation J Allergy Clin Immunol 133 2014 240 247
17. H. Tateno, P.R. Crocker, and J.C. Paulson Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand Glycobiology 15 2005 1125 1135
18. B.S. Bochner Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors Clin Exp Allergy 39 2009 317 324
19. J.Q. Zhang, B. Biedermann, L. Nitschke, and P.R. Crocker The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils Eur J Immunol 34 2004 1175 1184
20. G. Kano, M. Almanan, B.S. Bochner, and N. Zimmermann Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation J Allergy Clin Immunol 132 2013 437 445
21. E. Nutku, H. Aizawa, S.A. Hudson, and B.S. Bochner Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis Blood 101 2003 5014 5020
22. E. Nutku, S.A. Hudson, and B.S. Bochner Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury Biochem Biophys Res Commun 336 2005 918 924
23. E. Nutku-Bilir, S.A. Hudson, and B.S. Bochner Interleukin-5 priming of human eosinophils alters Siglec-8 mediated apoptosis pathways Am J Respir Cell Mol Biol 38 2008 121 124
24. S. von Gunten, S. Yousefi, M. Seitz, S.M. Jakob, T. Schaffner, and R. Seger Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment Blood 106 2005 1423 1431
25. R. Rashmi, B.P. Bode, N. Panesar, S.B. King, J.R. Rudloff, and M.R. Gartner Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils Pediatr Res 66 2009 266 271
26. S.J. McMillan, R.S. Sharma, H.E. Richards, V. Hegde, and P.R. Crocker Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung J Biol Chem 289 2014 20370 20376
27. H. Yokoi, O.H. Choi, W. Hubbard, H.S. Lee, B.J. Canning, and H.H. Lee Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by Siglec-8 engagement J Allergy Clin Immunol 121 2008 499 505
28. H. Mao, G. Kano, S.A. Hudson, M. Brummet, N. Zimmermann, and Z. Zhu Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen PLoS One 8 2013 e68143
29. T. Avril, H. Floyd, F. Lopez, E. Vivier, and P.R. Crocker The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells J Immunol 173 2004 6841 6849
30. S. Varchetta, E. Brunetta, A. Roberto, J. Mikulak, K.L. Hudspeth, and M.U. Mondelli Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes PLoS One 7 2012 e45821
31. T. Kiwamoto, N. Kawasaki, J.C. Paulson, and B.S. Bochner Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions Pharmacol Ther 135 2012 327 336
32. S. von Gunten, S.M. Jakob, B. Geering, J. Takala, and H.U. Simon Different patterns of Siglec-9-mediated neutrophil death responses in septic shock Shock 32 2009 386 392
33. S.A. Hudson, N. Bovin, R.L. Schnaar, P.R. Crocker, and B.S. Bochner Eosinophil-selective binding and pro-apoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis X J Pharmacol Exp Ther 330 2009 608 612
34. J.P. Guo, M.E. Brummet, A.C. Myers, H.J. Na, E. Rowland, and R.L. Schnaar Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs Am J Respir Cell Mol Biol 44 2011 238 243
35. M.L. Patnode, C.W. Cheng, C.C. Chou, M.S. Singer, M.S. Elin, and K. Uchimura Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue J Biol Chem 288 2013 26533 26545
36. T. Kiwamoto, T. Katoh, C.M. Evans, W.J. Janssen, M.E. Brummet, and S.A. Hudson Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis J Allergy Clin Immunol Dec 12, 2014 [E-pub ahead of print]. doi:10.1016/j.jaci.2014.10.027
37. A. Zarbock, K. Ley, R.P. McEver, and A. Hidalgo Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow Blood 118 2011 6743 6751
38. R.P. McEver, and C. Zhu Rolling cell adhesion Annu Rev Cell Dev Biol 26 2010 363 396
39. B.S. Bochner Road signs guiding leukocytes along the inflammation superhighway J Allergy Clin Immunol 106 2000 817 828
40. M.S. Sandrin, W.L. Fodor, E. Mouhtouris, N. Osman, S. Cohney, and S.A. Rollins Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis Nat Med 1 1995 1261 1267
41. C.H. Chung, B. Mirakhur, E. Chan, Q.T. Le, J. Berlin, and M. Morse Cetuximab-induced anaphylaxis and IgE specific for galactose-α1,3-galactose N Engl J Med 358 2008 1109 1117
42. J.W. Steinke, T.A.E. Platts-Mills, and S.P. Commins The alpha gal story: lessons learned from connecting the dots J Allergy Clin Immunol 135 2015 589 596
43. J.B. Oliveira, and T.A. Fleisher Laboratory evaluation of primary immunodeficiencies J Allergy Clin Immunol 125 Suppl 2010 S297 S305
44. S. von Gunten, D.F. Smith, R.D. Cummings, S. Riedel, S. Miescher, and A. Schaub Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass J Allergy Clin Immunol 123 2009 1268 1276.e15
45. M. Dalziel, M. Crispin, C.N. Scanlan, N. Zitzmann, and R.A. Dwek Emerging principles for the therapeutic exploitation of glycosylation Science 343 2014 1235681
46. N.S. Prasanphanich, A.E. Luyai, X. Song, J. Heimburg-Molinaro, M. Mandalasi, and M. Mickum Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite Glycobiology 24 2014 619 637
47. C.N. Scanlan, J. Offer, N. Zitzmann, and R.A. Dwek Exploiting the defensive sugars of HIV-1 for drug and vaccine design Nature 446 2007 1038 1045
48. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, and J.P. Julien Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
49. R.G. Webster, and E.A. Govorkova Continuing challenges in influenza Ann N Y Acad Sci 1323 2014 115 139
50. H. Rempel, C. Calosing, B. Sun, and L. Pulliam Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity PLoS One 3 2008 e1967
51. A.C. van der Kuyl, R. van den Burg, F. Zorgdrager, F. Groot, B. Berkhout, and M. Cornelissen Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression PLoS One 2 2007 e257
52. W.B. Puryear, X. Yu, N.P. Ramirez, B.M. Reinhard, and S. Gummuluru HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells Proc Natl Acad Sci U S A 109 2012 7475 7480
53. L. Kardava, S. Moir, W. Wang, J. Ho, C.M. Buckner, and J.G. Posada Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors J Clin Invest 121 2011 2614 2624
54. W. Chen, C. Han, B. Xie, X. Hu, Q. Yu, and L. Shi Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation Cell 152 2013 467 478
55. A. Varki Colloquium paper: uniquely human evolution of sialic acid genetics and biology Proc Natl Acad Sci U S A 107 Suppl 2 2010 8939 8946
56. A.F. Carlin, S. Uchiyama, Y.C. Chang, A.L. Lewis, V. Nizet, and A. Varki Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response Blood 113 2009 3333 3336
57. Y.C. Chang, and V. Nizet The interplay between Siglecs and sialylated pathogens Glycobiology 24 2014 818 825
58. T. Angata, T. Ishii, T. Motegi, R. Oka, R.E. Taylor, and P.C. Soto Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation Cell Mol Life Sci 70 2013 3199 3210
59. S.R. Ali, J.J. Fong, A.F. Carlin, T.D. Busch, R. Linden, and T. Angata Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus J Exp Med 211 2014 1231 1242
60. G.Y. Chen, N.K. Brown, W. Wu, Z. Khedri, H. Yu, and X. Chen Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1 Elife 3 2014 e04066
61. A. Etzioni, and M. Tonetti Leukocyte adhesion deficiency II-from A to almost Z Immunol Rev 178 2000 138 147
62. E. van de Vijver, A. Maddalena, O. Sanal, S.M. Holland, G. Uzel, and M. Madkaikar Hematologically important mutations: leukocyte adhesion deficiency (first update) Blood Cells Mol Dis 48 2012 53 61
63. B. Ferwerda, G. Ferwerda, T.S. Plantinga, J.A. Willment, A.B. van Spriel, and H. Venselaar Human dectin-1 deficiency and mucocutaneous fungal infections N Engl J Med 361 2009 1760 1767
64. E.O. Glocker, A. Hennigs, M. Nabavi, A.A. Schaffer, C. Woellner, and U. Salzer A homozygous CARD9 mutation in a family with susceptibility to fungal infections N Engl J Med 361 2009 1727 1735
65. J.N. Arnold, M.R. Wormald, R.B. Sim, P.M. Rudd, and R.A. Dwek The impact of glycosylation on the biological function and structure of human immunoglobulins Annu Rev Immunol 25 2007 21 50
66. I. Schwab, and F. Nimmerjahn Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13 2013 176 189
67. S. von Gunten, Y. Shoenfeld, M. Blank, D.R. Branch, T. Vassilev, and F. Kasermann IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist Nat Rev Immunol 14 2014 349
68. M. Debre, M.C. Bonnet, W.H. Fridman, E. Carosella, N. Philippe, and P. Reinert Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura Lancet 342 1993 945 949
69. A. Samuelsson, T.L. Towers, and J.V. Ravetch Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor Science 291 2001 484 486
70. Y. Kaneko, F. Nimmerjahn, and J.V. Ravetch Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science 313 2006 670 673
71. R.M. Anthony, F. Wermeling, M.C. Karlsson, and J.V. Ravetch Identification of a receptor required for the anti-inflammatory activity of IVIG Proc Natl Acad Sci U S A 105 2008 19571 19578
72. K. Masuda, T. Kubota, E. Kaneko, S. Iida, M. Wakitani, and Y. Kobayashi-Natsume Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity Mol Immunol 44 2007 3122 3131
73. S. Chung, Y.L. Lin, C. Reed, C. Ng, Z.J. Cheng, and F. Malavasi Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells J Immunol Methods 407 2014 63 75
74. R. Kolbeck, A. Kozhich, M. Koike, L. Peng, C.K. Andersson, and M.M. Damschroder MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function J Allergy Clin Immunol 125 2010 1344 1353.e2
75. C. Jandus, K.F. Boligan, O. Chijioke, H. Liu, M. Dahlhaus, and T. Demoulins Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance J Clin Invest 124 2014 1810 1820
76. J.E. Hudak, S.M. Canham, and C.R. Bertozzi Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion Nat Chem Biol 10 2014 69 75
77. M.J. Paszek, C.C. DuFort, O. Rossier, R. Bainer, J.K. Mouw, and K. Godula The cancer glycocalyx mechanically primes integrin-mediated growth and survival Nature 511 2014 319 325
78. T. Kimura, and O.J. Finn MUC1 immunotherapy is here to stay Expert Opin Biol Ther 13 2013 35 49
79. S. Mizrahi, B.F. Gibbs, L. Karra, M. Ben-Zimra, and F. Levi-Schaffer Siglec-7 is an inhibitory receptor on human mast cells and basophils J Allergy Clin Immunol 134 2014 230 233.e3
80. N. Zimmermann, M.L. McBride, Y. Yamada, S.A. Hudson, C. Jones, and K.D. Cromie Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils Allergy 63 2008 1156 1163
81. D.J. Song, J.Y. Cho, S.Y. Lee, M. Miller, P. Rosenthal, and P. Soroosh Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling J Immunol 183 2009 5333 5341
82. E. Rubinstein, J.Y. Cho, P. Rosenthal, J. Chao, M. Miller, and A. Pham Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis J Pediatr Gastroenterol Nutr 53 2011 409 416
83. D.J. Song, J.Y. Cho, M. Miller, W. Strangman, M. Zhang, and A. Varki Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model Clin Immunol 131 2009 157 169
84. M. Zhang, T. Angata, J.Y. Cho, M. Miller, D.H. Broide, and A. Varki Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils Blood 109 2007 4280 4287
85. J.Y. Cho, D.J. Song, A. Pham, P. Rosenthal, M. Miller, and S. Dayan Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13 Respir Res 11 2010 154
86. M. Suzukawa, M. Miller, P. Rosenthal, J.Y. Cho, T.A. Doherty, and A. Varki Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice J Immunol 190 2013 5939 5948
87. T. Kiwamoto, T. Katoh, M. Tiemeyer, and B.S. Bochner The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation Curr Opin Allergy Clin Immunol 13 2013 106 111
88. G.Y. Chen, N.K. Brown, P. Zheng, and Y. Liu Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity Glycobiology 24 2014 800 806
89. J. Muller, and L. Nitschke The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease Nat Rev Rheumatol 10 2014 422 428
90. G.Y. Chen, J. Tang, P. Zheng, and Y. Liu CD24 and Siglec-10 selectively repress tissue damage-induced immune responses Science 323 2009 1722 1725
91. A. Hoffmann, S. Kerr, J. Jellusova, J. Zhang, F. Weisel, and U. Wellmann Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population Nat Immunol 8 2007 695 704
92. S. Bokers, A. Urbat, C. Daniel, K. Amann, K.G. Smith, and M. Espeli Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice J Immunol 192 2014 2994 3002
93. T. Toubai, G. Hou, N. Mathewson, C. Liu, Y. Wang, and K. Oravecz-Wilson Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice Blood 123 2014 3512 3523
94. J. Jellusova, U. Wellmann, K. Amann, T.H. Winkler, and L. Nitschke CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity J Immunol 184 2010 3618 3627
95. E. Bandala-Sanchez, Y. Zhang, S. Reinwald, J.A. Dromey, B.H. Lee, and J. Qian T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10 Nat Immunol 14 2013 741 748
96. T. Grader-Beck, F. Boin, S. von Gunten, D. Smith, A. Rosen, and B.S. Bochner Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease Ann Rheum Dis 70 2011 2218 2224
97. I. Dotan, S. Fishman, Y. Dgani, M. Schwartz, A. Karban, and A. Lerner Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease Gastroenterology 131 2006 366 378
98. N. Dotan, R.T. Altstock, M. Schwarz, and A. Dukler Anti-glycan antibodies as biomarkers for diagnosis and prognosis Lupus 15 2006 442 450
99. C.D. Rillahan, E. Schwartz, R. McBride, V.V. Fokin, and J.C. Paulson Click and pick: identification of sialoside analogues for siglec-based cell targeting Angew Chem Int Ed Engl 51 2012 11014 11018
100. C.M. Nycholat, C. Rademacher, N. Kawasaki, and J.C. Paulson In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages J Am Chem Soc 134 2012 15696 15699
101. C.D. Rillahan, M.S. Macauley, E. Schwartz, Y. He, R. McBride, and B.M. Arlian Disubstituted sialic acid ligands targeting Siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas Chem Sci 5 2014 2398 2406
102. M.K. O'Reilly, and J.C. Paulson Siglecs as targets for therapy in immune-cell-mediated disease Trends Pharmacol Sci 30 2009 240 248
103. N. Kawasaki, J.L. Vela, C.M. Nycholat, C. Rademacher, A. Khurana, and N. van Rooijen Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation Proc Natl Acad Sci U S A 110 2013 7826 7831
104. N. Kawasaki, C.D. Rillahan, T.Y. Cheng, I. Van Rhijn, M.S. Macauley, and D.B. Moody Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation J Immunol 193 2014 1560 1566
105. B.H. Duong, H. Tian, T. Ota, G. Completo, S. Han, and J.L. Vela Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo J Exp Med 207 2010 173 187
106. M.S. Macauley, F. Pfrengle, C. Rademacher, C.M. Nycholat, A.J. Gale, and A. von Drygalski Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis J Clin Invest 123 2013 3074 3083
107. F. Pfrengle, M.S. Macauley, N. Kawasaki, and J.C. Paulson Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22 J Immunol 191 2013 1724 1731
108. S. von Gunten, A. Schaub, M. Vogel, B.M. Stadler, S. Miescher, and H.U. Simon Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations Blood 108 2006 4255 4259
109. S. von Gunten, M. Vogel, A. Schaub, B.M. Stadler, S. Miescher, and P.R. Crocker Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies J Allergy Clin Immunol 119 2007 1005 1011
110. T. Wun, L. Styles, L. DeCastro, M.J. Telen, F. Kuypers, and A. Cheung Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia PLoS One 9 2014 e101301
111. J. Chang, J.T. Patton, A. Sarkar, B. Ernst, J.L. Magnani, and P.S. Frenette GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice Blood 116 2010 1779 1786
112. M. Collin, O. Shannon, and L. Bjorck IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions Proc Natl Acad Sci U S A 105 2008 4265 4270
113. C. Lood, M. Allhorn, R. Lood, B. Gullstrand, A.I. Olin, and L. Ronnblom IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum 64 2012 2698 2706
114. K.S. Nandakumar, M. Collin, K.E. Happonen, A.M. Croxford, S.L. Lundstrom, and R.A. Zubarev Dominant suppression of inflammation by glycan-hydrolyzed IgG Proc Natl Acad Sci U S A 110 2013 10252 10257